METTL3 amplifies the translation of SCAP mRNA in NAFLD-HCC, promoting cholesterol biosynthesis while simultaneously impairing the cytotoxic capacity of CD8+ T cells. The gene discussed is METTL3; the disease is metabolic dysfunction-associated steatotic liver disease.